Naslov: | The Chronic Urticaria Registry (CURE) : rationale, methods, and initial implementation |
---|
Avtorji: | ID Weller, Karsten (Avtor) ID Giménez-Arnau, Ana M. (Avtor) ID Grattan, Clive (Avtor) ID Asero, Riccardo (Avtor) ID Mathelier-Fusade, Pascale (Avtor) ID Bizjak, Mojca, Klinika Golnik (Avtor) ID Hanna, Michael (Avtor) ID Maurer, Marcus (Avtor) |
Datoteke: | PDF - Predstavitvena datoteka, prenos (252,21 KB) MD5: A6759881F8489241A254C3F1F76CF4BF
URL - Predstavitvena datoteka, za dostop obiščite https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16947
|
---|
Jezik: | Angleški jezik |
---|
Tipologija: | 1.03 - Drugi znanstveni članki |
---|
Organizacija: | UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
|
---|
Povzetek: | Background: Chronic urticaria (CU) is a common disease, characterized by the recurrent appearance of wheals, angioedema, or both for more than 6 weeks. Its underlying biology is not well understood, and many patients do not obtain sufficient relief from recommended treatments. Patient registries are rapidly growing as a form of research, because they can provide powerful, data-driven insights about the epidemiology of diseases, real-world effectiveness of treatments, rare patient types, safety monitoring, healthcare costs, and opportunities for quality improvement of healthcare delivery. Objectives: The Chronic Urticaria Registry (CURE) has been designed to improve the scientific understanding, clinical treatment, and healthcare planning of chronic urticaria patients. This report describes the rationale, methods, and initial implementation of this registry. Methods: CURE is an ongoing, prospective, international, multicenter, observational, voluntary registry of patients with CU. Participation in CURE is open to any physician treating CU patients, regardless of location, medical specialty, or type of practice setting. CURE aims to collect data on all CU patients, with no intentional selection or exclusion criteria. It collects baseline and follow-up data on the patient's demographics, history, symptoms, trigger and risk factors, therapies, and healthcare utilization. Results: CURE is a landmark achievement of the global urticaria medical community. As of 26 February 2020, 39 centers around the world have joined the registry and 35 have entered baseline data on a total of 2946 patients. Publications of this data will be forthcoming soon. Conclusions: CURE is eagerly seeking the participation of more physicians and the support of more governmental, charitable, and commercial sponsors from around the world. Here, in this paper, we invite other physicians to join this unique project to improve the lives of patients with CU. |
---|
Ključne besede: | urticaria, registries |
---|
Status publikacije: | V tisku |
---|
Verzija publikacije: | Recenzirani rokopis |
---|
Kraj izida: | ZDA |
---|
Založnik: | John Wiley & Sons |
---|
Leto izida: | 2020 |
---|
Št. strani: | str. [1-22] |
---|
Številčenje: | Vol. 34, no. |
---|
PID: | 20.500.12556/DiRROS-12523 |
---|
UDK: | 616-097 |
---|
ISSN pri članku: | 1468-3083 |
---|
DOI: | 10.1111/jdv.16947 |
---|
COBISS.SI-ID: | 29914115 |
---|
Avtorske pravice: | © 2020 The Authors. |
---|
Opomba: | Nasl. z nasl. zaslona;
Opis vira z dne 25. 9. 2020;
Soavtorica iz Slovenije: Mojca Bizjak;
|
---|
Datum objave v DiRROS: | 07.10.2020 |
---|
Število ogledov: | 1766 |
---|
Število prenosov: | 946 |
---|
Metapodatki: | |
---|
:
|
Kopiraj citat |
---|
| | | Objavi na: | |
---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |